Capital Area Health Consortium
Overview
Capital Area Health Consortium sponsors a self-funded health plan that covered 834 participants in plan year 2024. The plan year starts in July. Alongside medical, its benefits filing reports life insurance, dental, vision, long-term disability, and more.
- Plan type
- ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
- Participants
- 834
- Plan year
- Begins July 1 · next renewal July 2027
- Health plans filed
- Capital Area Health Consortium Medical Benefits Plan, plan 510 (834 participants)
- Broker compensation
- $21K across insured contracts
Insurance carriers
Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.
| Carrier | Coverage | Covered | Premium | Broker comp |
|---|---|---|---|---|
| The Guardian Life Insurance Company of America | Long-term disability | 831 | $104K | $16K |
| Standard Insurance Company | Life | 834 | $50K | $5K |
Pharmacy benefit estimate
StreamRX estimate for a plan this size. Not based on this plan's claims.
Estimated prescription spend: 834 participants × $2,371 national average per member. Usually higher once dependents are counted.
Typical savings opportunity found in independent reviews of plans this size.
Form 5500 filing details
- Filing
- Form 5500 with Schedule A, plan year 2024
- Plan sponsor
- Capital Area Health Consortium
- Sponsor EIN
- 51-0173264
- Plan number
- 510
- Filed with
- U.S. Department of Labor (EBSA) via EFAST2
Verify this filing: search EIN 51-0173264 in the Department of Labor's EFAST2 Form 5500 search.
About this data
Source: Capital Area Health Consortium's Form 5500 filing for plan year 2024 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Capital Area Health Consortium.